American Society of Interventional Pain Physicians | April 10, 2019

Time to Make Plans To Attend ASIPP 21 st Annual Meeting
Room Block Extended!
Join Us in Vegas! Come to the Annual Meeting on May 3-5!

The Annual ASIPP® meeting is one the most exciting and educational meetings in the world . We bring to you the most renown speakers who will deliver the highest caliber lectures. Th is year’s A nnual M eeting features 11 exemplary keynote speakers, more than 60 distinguished speakers, nearly 80 key topics – all related to interventional pain management .  
abipp logo
ABIPP Part 1 Chicago, June 9
June 9 | Chicago, IL
 
The American Board of Interventional Pain Physicians ( ABIPP ) has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management
profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become ABIPP certified.
 
Register
 
April 1 to April 15, 2019, fee is $2,000
 
April 16 to April 30, fee is total of $3,000
 
No registrations after April 30
 
 
For complete information about the examination requirements and to obtain an application packet, visit www.abipp.org or call 270-554-9412 x4217 or by email at summer@asipp.org.
 
JULY ABIPP EXAMS
AND COMPETENCY EXAMS
July 13 - July 14 | Memphis, TN
 
The American Board of Interventional Pain Physicians ( ABIPP ) has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management
profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become ABIPP certified.

Register

May1 to May 15, 2019, fee is $2,000

May 16 to May 30, fee is total of $3,000

No registrations after May 30.

 
ABIPP now offers the only competency certification program for regenerative medicine.
 
For complete information about the examination requirements and to obtain an application packet, visit www.abipp.org or call 270-554-9412 x4217 or by email at summer@asipp.org.

July 13
ABIPP Part I

July 13
ABIPP Part I
 
July 13-14
ABIPP Part II
 
July 14
ABIPP Competency Exam

July 13
Combined CSM/CCPM Exam for ABIPP Path
July 13
Competency Exam in Controlled Substance Management

July 13
Competency Exam in Coding, Compliance, and
Practice Management

July 13-14
Regenerative Medicine Competency Exam
 
July 13-14
Endoscopic Lumbar Decompression Competency Exam

939 Ridge Lake Blvd. | Memphis, TN 38120
 
The cut-off date for our room block with discounted rates is on June 10, 2019 or until sold out, whichever occurs first.
REGISTRATION        HOTEL
Interventional Pain Management Reports is an Open Access online journal, a peer-reviews journal dedicated to the publication of case reports, brief commentaries and reviews and letters to the editor. It is a peer-reviewed journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine. 

Interventional Pain Management Reports is an official publication of the American Society of Interventional Pain Physicians (ASIPP) and is a sister publication of Pain Physician . Interventional Pain Management Reports Interventional Pain Management Reports is an open access journal, available online with free full manuscripts.  

The benefits of publishing in an open access journal that has a corresponding
print edition journal are:  
  • Your article will have the potential to obtain more citations.
  • Your article will be peer-reviewed and published faster than other journals.
  • Your article can be read by a potentially much larger audience compared with traditional subscription-only journals.  
  • Open Access journals are FREE to view, download and to print.

So submit today your:
  • Case Reports
  • Technical Reports
  • Editorials
  • Short Perspectives

New York attorney general sues stem cell clinic over unproven procedures — 8 insights

New York Attorney General Letitia James is suing New York City-based Park Avenue Stem Cell alleging the clinic performed unproven and rogue procedures on patients, the New York Times reports.
What you should know:
1. Ms. James alleged the clinic used stem cells to treat conditions like erectile dysfunction and heart disease.
2. She said in a statement, "Misleading vulnerable consumers who are desperate to find a treatment for serious and painful medical conditions is unacceptable, unlawful and immoral."
3. The Attorney General's Office is attempting to police the unethical claims made by stem cell clinics in New York, following in the FDA's national efforts. The FDA warned several clinics to stop performing dangerous, untested treatments earlier in the week and sued several others in 2018.


Virtual Simulations Offer a Cure to Doctors’ Poor Bedside Manner

The bedside manner of doctors, nurses and other caregivers is getting a boost from an unexpected source: artificial intelligence.
Virtual simulations that incorporate AI are making their way into medical training programs across the country, placing caregivers in the role of patients or having them interact in their real-life roles with virtual patients. The simulations aim to help train health-care workers to be more empathetic and improve difficult conversations with patients suffering from a wide range of conditions including Alzheimer’s, cancer and substance addictions.


Access to this article may be limited
Treating Depression, Obesity, and Chronic Pain by Targeting One Protein

Major depression, obesity, and chronic pain are all linked to the effects of one protein, called “FK506-binding protein 51,” or FKBP51. Until now, efforts to inhibit this target have been hampered by the difficulty of finding something specific enough to do the job and not affect similar proteins.
Now a research group has developed a highly selective compound that can effectively block FKBP51 in mice, relieving chronic pain and having positive effects on diet-induced obesity and mood. The new compound also could have applications in alcoholism and brain cancer.


Multidrug-resistant infections cost hospitals $2.4B annually

Hospitals spend more than $2 billion annually to treat patients with multidrug-resistant infections, according to a study published in Health Services Research.
For the study, researchers used multivariable regression models to assess hospitalization costs and length of stay for 6.4 million inpatient stays involving bacterial infections in 2014.
Three study findings:
1. At least 10.8 percent of inpatient stays involving a bacterial infection showed evidence of one or more multidrug-resistant organisms.
2. Researchers estimated the cost of treating multidrug-resistant infections in the inpatient setting is at least $2.39 billion annually. When accounting for undercoded infections, this estimate jumps to $3.38 billion.
3. Researchers also estimated additional costs per inpatient stay for the following types of infections:
  • Methicillin-resistant Staphylococcus aureus — $1,718
  • Clostridium difficile — $4,617
  • Infection with a different multidrug-resistant organism — $2,302
  • Infection with more than one multidrug-resistant organism — $3,570


21% of HAIs waterborne, study finds
 
A little over 20 percent of healthcare-associated infections can be transmitted via water, according to a study published in Infection Control & Hospital Epidemiology.
Researchers examined internal CDC records from Jan. 1, 2014, through Dec. 31, 2017. They used water-related terms and organisms, except for Legionella, to find CDC consultations that involved transmission of water-related organisms in healthcare settings.
Of 620 consultations, researchers found 134 (21.6 percent) that involved the investigation of potential water-related HAIs or infection control lapses that gave rise to the potential for water-related HAIs. Around 30 percent of consultations involved nontuberculous mycobacteria, and 35. 8 percent involved medical products.



  A Prescriber’s Guide to the New Medicare Part D Opioid Overutilization Policies for 2019

The Centers for Medicare & Medicaid Services (CMS) understands the magnitude of our nation’s opioid epidemic and its impact on communities. Opioid medications are effective at treating certain types of pain, but have serious risks such as increasing tolerance, addiction, overdose, and death. Given the scope of the crisis, CMS published a roadmap in June 2018 outlining our efforts to address this issue. The roadmap details our three-pronged approach to combating the opioid epidemic going forward: 1) prevention of new cases of opioid use disorder (OUD); 2) treatment of patients who have already become dependent on or addicted to opioids; and 3) utilization of data from across the country to better target prevention and treatment activities. Through our 2019 Medicare Part D opioid overutilization initiatives, CMS seeks to strengthen and broaden our partnership with providers to address the opioid crisis.

CMS
2019 MIPS Reporting? Start Now.
MIPS-eligible clinicians must report a full year of data. Don’t fall behind – keep up with NIPM-QCDR.
 
MIPS 2019 has brought larger payment adjustments and greater reporting requirements, including a 365-day performance period for the Quality and Cost categories. The sooner you start your MIPS reporting for 2019, the better.
Sign up today to use ASIPP’s NIPM-QCDR for MIPS.
This powerful tool makes MIPS reporting easy through the use of our new patient-reported outcomes measures for 2019, which ease the burden on providers and reduces costly EMR integration.

Get started today at ASIPP.ArborMetrix.net

Many Young Adults Report Using Cannabis for Chronic Pain

A large percentage of young adults who use cannabis were found to resort to this option for chronic pain management , according to a study published in the Journal of Pain.
Researchers collected cross-sectional survey data of 143 young adults (mean age, 23.85 years) who used cannabis and resided in the Pacific Northwest. A subset of participants with chronic pain were subsequently enrolled in a secondary study (n=25). The investigators collected demographic data as well as pain history and characteristics, including pain intensity assessed with an 11-point numeric rating scale. Participants were asked to identify pain locations by clicking on areas of a body map on a computer. Pain-related disability and the frequency of cannabis use and cannabis-related problems were assessed with the PROMIS v1.0-Pain Interference-Short Form 8a and the Rutgers Marijuana Problem Index, respectively.



Pain Physician
March/April 2019 Issue Features

Systematic Review
Ian D. Coulter, PhD, Cindy Crawford, BA, Howard Vernon, DC. PhD, Eric L. Hurwitz, DC. PhD, Raheleh Khorsan, PhD, Marika Suttorp Booth, MS, and Patricia M. Herman, ND, PhD

Systematic Review
Nitika Sanger, HBSc, Meha Bhatt, MSc, Nikhita Singhal, BHSc, Katherine Ramsden, MD, Natasha Baptist-Mohseni, BSc, Balpreet Panesar, BSc, Hamnah Shahid, BASc, Alannah Hillmer, BSc, Alessia D'Elia, BSc, Candice Luo, BHSc, Victoria Rogers, BSc, Abirami Arunan, HBSc, Lola Baker-Beal, BSc, Sean Haber, BSc, Jihane Henni, BSc, Megan Puckering, BSc, Sunny Sun, BSc, Kim Ng, BSc, Stephanie Sanger, MLIS, Natalia Mouravaska, MD, M. Constantine Samaan, MD, Russell de Souza, ScD, Lehana Thabane, PhD, and Zainab Samaan, PhD

Randomized Trial
Doo-Hwan Kim, MD, Myung-Su Lee, MD, Sookyung Lee, MD, Syn-Hae Yoon, MD, Jin-Woo Shin, MD, PhD, and Seong-Soo Choi, MD, PhD

Randomized Controlled Trial
Neerja Bharti, MD, John Sujith, MD, Navneet Singla, Mch, Nidhi B. Panda, MD, and Indu Bala, MD.


NIH launches 1st in-human trial of universal flu vaccine

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, started the first in-human clinical trial of a new universal influenza vaccine candidate.
The experimental vaccine, known as H1ssF_3928, was developed to help the body respond to different flu subtypes by focusing on the aspects of the virus that remain mostly the same among various strains.
The trial will enroll at least 53 adults, ranging from 18 to 70 years. The first five participants, aged 18 to 40 years, will receive a single 20-microgram injection of the vaccine, while the remaining participants will receive two 60- microgram injections spaced 16 weeks apart.

NIH

Ex-Florida hospital director gets prison time for role in $1B fraud scheme
The former director of outreach programs at Larkin Community Hospital in South Miami, Fla., was sentenced to 15 months in prison April 3 for her role in a $1 billion healthcare fraud scheme.
Four things to know:
1. The judge handed down the sentence just over two months after Odette Barcha pleaded guilty to conspiring to defraud the federal government and paying and receiving healthcare kickbacks.
2. Ms. Barcha was one of three defendants charged in an indictment unsealedin July 2016. She allegedly had physicians at Larkin Community Hospital discharge patients to skilled nursing homes and other facilities owned by Philip Esformes, who allegedly paid kickbacks for those admissions.
3. Prosecutors allege Mr. Esformes, who operated a network of more than 30 skilled nursing homes and assisted living facilities in Florida, admitted Medicare and Medicaid beneficiaries to the facilities even if they did not qualify for skilled nursing home care or for placement in an assisted living facility. Once admitted, the patients received medically unnecessary care that was billed to Medicare and Medicaid.
4. The seven-week trial of Mr. Esformes wrapped up March 29, according to the Miami Herald . On April 5, a federal jury found Mr. Esformes guilty of various counts, including paying and receiving kickbacks, bribery, money laundering and obstruction of justice, according to  Law360


South Florida Health Care Facility Owner Convicted for Role in Largest Health Care Fraud Scheme Ever Charged by The Department of Justice, Involving $1.3 Billion in Fraudulent Claims

A federal jury found a South Florida health care facility owner guilty today for his role in the largest health care fraud scheme ever charged by the Justice Department, involving over $1.3 billion in fraudulent claims to Medicare and Medicaid for services that were not provided, were not medically necessary or were procured through the payment of kickbacks. 
After an eight-week trial, Philip Esformes, 50, of Miami Beach, Florida, was convicted of one count of conspiracy to defraud the United States, two counts of receipt of kickbacks in connection with a federal health care program, four counts of payment of kickbacks in connection with a federal health care program, one count of conspiracy to commit money laundering, nine counts of money laundering, two counts of conspiracy to commit federal program bribery, and one count of obstruction of justice before U.S. District Judge Robert N. Scola Jr. of the Southern District of Florida. Sentencing has not yet been scheduled.

DOJ
State Society News 

July 12-14, 2019
GSIPP 2019 - 15th Annual Meeting & Pain Summit
The Cloister Hotel at Sea Island
Sea Island, GA
For more information, contact Karrie Kirwan at karrie@theassociationcompany.com or Tara Morrison at tara@theassociationcompany.com or 770-613-0932.

July 26-28, 2019
PAIN 2019
West Virginia Society of Pain Physicians
Loews Miami Beach, FL


Send in your state society meeting news to Holly Long, hlong@asipp.org
ASIPP | Pain Physician Journal | Phone | Fax | Email